10:15 AM EDT, 04/07/2025 (MT Newswires) -- XTL Biopharmaceuticals (XTLB) said Monday it named Noam Band as its new chief executive officer to succeed Shlomo Shalev.

Shalev will remain as XTL Biopharmaceuticals' chairman, the company said.

Shares of XTL Biopharmaceuticals were up over 22% in recent Monday trading.

Price: 1.21, Change: +0.22, Percent Change: +22.22